NCT07491172: A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- State
- Under way
- Phase
- Phase 1
- People
- 90 planned
- Started
- 21 Jun 2024
- Primary completion
- Jun 2027
- Arms
- CTX310
- Results
- None posted
- 21 Jun 2024: Trial started
- 24 Mar 2026: Trial registered